“…PRIMA-1 tended to increase phosphatidylserine exposure at lower concentrations (10 µM), an effect, however, not reaching statistical significance. It must be kept in mind that erythrocytes may be sensitized to the effect of PRIMA-1 by other xenobiotics stimulating cell membrane scrambling [35,49,50,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82] or by diseases associated with enhanced cell membrane scrambling, such as sepsis, malaria, sickle cell disease, Wilson's disease, iron deficiency, malignancy, metabolic syndrome, diabetes, hepatic failure, renal insufficiency, hemolytic uremic syndrome, hyperphosphatemia and phosphate depletion [34,83,84]. …”